Related Experiment Video
Updated: Jan 3, 2026

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis
Xingyun Wang1,2, Shilin Xia3, Hongchang Li4
1Institute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
Abstract:
Krüppel-like factor 4 (KLF4), a key transcription factor, acts as a multifunctional player involved in the progression of numerous aggressive cancers. The proteasome-dependent pathway is one of the main modalities in controlling KLF4 abundance at a posttranslational level. Although some of the ubiquitin ligases have been identified, the deubiquitinases of KLF4 and the regulatory function remain unexplored. Here, by screening ubiquitin-specific proteases that may interact with KLF4, we found ubiquitin-specific peptidase 10 (USP10) as a deubiquitinating enzyme for KLF4. Forced expression of USP10 remarkably increases KLF4 protein level by blocking the latter degradation, whereas the depletion of USP10 promotes KLF4 degradation and thus enhances tumorigenesis. Loss of USP10 in mice downregulates KLF4 expression and accelerates KrasG12D-driven lung adenocarcinoma initiation and progression. In addition, our data revealed that KLF4 can facilitate the transcription of tumor suppressor TIMP3 by directly binding to the TIMP3 promoter. Clinically, reduction of USP10 expression, concomitant with decreased KLF4 and TIMP3 abundance in carcinoma tissue, predicts poor prognosis of lung cancer patient. Taken together, our results demonstrate that USP10 is a critical regulator of KLF4, pinpointing USP10-KLF4-TIMP3 axis as a promising therapeutic target in lung cancer.
Insights
Ubiquitin-specific peptidase 10 (USP10) stabilizes Krüppel-like factor 4 (KLF4) protein levels, inhibiting lung cancer progression. Loss of USP10 accelerates tumor growth, highlighting the USP10-KLF4-TIMP3 pathway as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Krüppel-like factor 4 (KLF4) is crucial in aggressive cancer progression.
- Protein stability, regulated by ubiquitination and deubiquitination, controls KLF4 levels.
- Deubiquitinases targeting KLF4 remain largely uncharacterized.
Purpose of the Study:
- To identify deubiquitinating enzymes that regulate KLF4.
- To elucidate the role of USP10 in KLF4 stability and cancer.
- To investigate the therapeutic potential of the USP10-KLF4-TIMP3 axis in lung cancer.
Main Methods:
- Screening of ubiquitin-specific proteases for KLF4 interaction.
- Functional assays involving USP10 overexpression and depletion.
- In vivo studies using KrasG12D-driven lung adenocarcinoma mouse models.
- Analysis of KLF4 binding to the TIMP3 promoter.
- Clinical correlation analysis of USP10, KLF4, and TIMP3 expression in lung cancer patients.
Main Results:
- Ubiquitin-specific peptidase 10 (USP10) was identified as a KLF4 deubiquitinase.
- USP10 overexpression stabilizes KLF4, while USP10 depletion promotes KLF4 degradation and tumorigenesis.
- Loss of USP10 accelerated KrasG12D-driven lung adenocarcinoma in mice.
- KLF4 directly promotes transcription of the tumor suppressor TIMP3.
- Reduced USP10, KLF4, and TIMP3 expression correlated with poor prognosis in lung cancer patients.
Conclusions:
- USP10 is a critical regulator of KLF4 stability.
- The USP10-KLF4-TIMP3 signaling axis plays a significant role in lung cancer.
- Targeting the USP10-KLF4-TIMP3 pathway offers a promising therapeutic strategy for lung cancer.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

